Azelis, the speciality chemicals company, has partnered with Tagra Biotechnologies to distribute its range of active ingredients for personal care applications in China.
The latest agreement builds on Azelis' existing partnership with Tagra in Europe, Canada, Australia and New Zealand, and the company hopes it will reinforce its position as a leading speciality chemicals distributor in the Asia Pacific region.
Laurent Nataf, Azelis' CEO and President Asia Pacific, said: “We are delighted to expand our partnership with Tagra once again into the Asia Pacific region.
“We both have a high focus on innovation and Tagra’s cutting edge ingredients represent a perfect fit for both our portfolio and our strategy to focus on creating value for our customers in Asia Pacific.”
Tagra Biotechnologies offers a variety of speciality cosmetics ingredients, including its patented Release on Demand (RND) Microencapsulation Technology which the company says provides stability and efficiency for non-water soluble ingredients, suitable for use in a wide range of personal care products.
Lito Ickowicz, Director of Business Development at Tagra Biotechnologies, added: “Azelis is a long-trusted partner of Tagra, so the decision to further expand into China with them came naturally to us.
“Together we aim to offer customers high quality technical service and innovative application insights.”
Azelis has been building on its global resources and growth into more markets worldwide; the company recently acquired its New Zealand and Australian rival company Chemcolour.
